Life360 Inc SEC Filings

Life360, Inc. insider Lauren Antonoff filed a Form 144 to sell 4,546 common shares through Fidelity Brokerage Services with an approximate aggregate market value of $409,140, and an intended sale date of 08/25/2025. The shares were acquired on 06/20/2024 via restricted stock vesting and were received as compensation. The filing reports total outstanding shares of 77,548,651. The notice also discloses four prior sales by the same person in the past three months totaling 32,446 shares for gross proceeds of $2,125,940.60.

Form 144 filed for Life360, Inc. (LIF) reporting a proposed sale of 500 common shares to be executed approximately on 08/25/2025 through Fidelity Brokerage Services. The shares were acquired on 09/19/2024 upon restricted stock vesting and were issued as compensation. The filing lists 77,548,651 shares outstanding for the issuer and an aggregate market value for the proposed sale of $45,000.00.

The filing also discloses prior sales by the same person during the past three months totaling 6,387 shares with gross proceeds of $419,445.40, consisting of multiple transactions between 05/27/2025 and 08/11/2025. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.

John Philip Coghlan, a director of Life360, Inc. (LIF), reported securities transactions on a Form 4. On 08/15/2025 he sold 10,000 shares of Life360 common stock at a weighted average price of $85.01 per share, with sale prices in the range of $85.00 to $85.10. After the reported transactions the filing shows the reporting person beneficially owns 67,604 shares indirectly held by the John Philip Coghlan 2025 Grantor Retained Annuity Trust and 12,500 shares indirectly held by the John Coghlan Living Trust. The filing also records 3,344 restricted stock units (described as contingent rights to receive common shares upon vesting). The Form 4 is signed by an attorney-in-fact on 08/22/2025.

Life360, Inc. (LIF) Form 144 notice reports a proposed sale of 20,000 common shares by a holder through Charles Schwab, with an aggregate market value of $1,734,400.00. The shares represent a small fraction of the company's 77,548,651 shares outstanding. The filer acquired the shares in a private placement on 10/24/2011 and paid via wired funds. The planned sale is approximately dated 08/22/2025 and the securities are listed on NASDAQ. The filer certifies no undisclosed material adverse information and no securities of the issuer were sold by the filer in the past three months.

Life360, Inc. (LIF) director James Synge reported multiple open-market dispositions of common stock equivalents tied to Australian CDIs between August 15 and August 18, 2025. The filings show sales of 24,919 and 81 common-stock-equivalent shares on August 15 at weighted average prices of $84.23 and $85.25 respectively, and a further 25,000 shares on August 18 at a weighted average price of $85.80, reflecting conversions from CDIs using a 1:3 ratio and AUD-to-USD exchange rates. After these transactions the reporting person directly held 194,754 common shares and indirectly held 3,966 shares through ICCA Labs, LLC, and the reported holdings include 2,810 unvested restricted stock units.

Charles J. Prober, a director of Life360, Inc. (LIF), reported routine insider transactions executed under a pre-established Rule 10b5-1 trading plan adopted March 14, 2025. On 08/13/2025 the filing shows a stock option exercise/acquisition of 7,930 shares at an exercise price of $11.18, which increased his beneficial ownership to 113,386 shares (this total includes 2,714 restricted stock units). The same day the plan shows the sale of 7,930 shares at $84.13, leaving him with 105,456 shares beneficially owned following the reported transactions. The Form 4 is signed by an attorney-in-fact on 08/15/2025.

Life360, Inc. Form 144 notice reports a proposed sale of 10,000 common shares through The Charles Schwab Corporation with an aggregate market value of $845,800.00, scheduled approximately for 08/15/2025 on NASDAQ. The filing shows the shares were acquired as executive compensation on 10/10/2013. It also discloses three recent sales by John Coghlan in the past three months: 3,125 shares on 06/02/2025 (proceeds $190,605.11), 3,125 shares on 07/01/2025 ($205,934.79), and 3,125 shares on 08/01/2025 ($229,774.48). The filer affirms no undisclosed material adverse information.

Life360, Inc. (LIF) Form 144 reports a proposed sale under Rule 144 of 7,930 shares of common stock to be sold through Fidelity Brokerage Services LLC on 08/13/2025 with an aggregate market value of $667,150.90. The filing shows 77,548,651 shares outstanding.

The securities-to-be-sold table lists the acquisition as Option Granted 04/12/2022 with a date shown as 08/13/2025 and payment as cash. The filing also discloses two recent sales by Charles Prober: 7,942 shares on 06/13/2025 for $489,465.46 and 7,930 shares on 07/14/2025 for $510,771.30. The filer includes the required representation about lacking undisclosed material adverse information.

Life360 reported strong operational growth for the quarter ended June 30, 2025. Total revenue rose to $115.4 million (up 36% year-over-year), driven by subscription revenue of $88.6 million (up 35%) and a doubling of other revenue to $14.5 million. Gross profit increased to $90.5 million, and the company reported operating income of $2.0 million and net income of $7.0 million for the quarter, reversing prior-period losses.

Life360 strengthened liquidity and strategic positioning: cash and cash equivalents rose to $432.7 million, the company issued $320.0 million of 0.00% convertible senior notes (net carrying amount $309.3 million) and recorded a $33.7 million purchase of capped calls that reduced additional paid-in capital. The company made a $25.0 million convertible note investment in Aura, completed a $4.5 million asset purchase from Fantix, and reported remaining performance obligations of $234.6 million (38% expected to be recognized within 12 months). The filing also discloses customer and supplier concentration (Apple ~54% of revenue; a sole contract manufacturer).